Share Price and Basic Stock Data
Last Updated: January 22, 2026, 7:54 am
| PEG Ratio | 23.96 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
S H Kelkar & Company Ltd (SHK) operates within the chemicals sector, specifically in the “Others” category, focusing on specialty chemicals. As of the latest reporting, the company’s stock price stood at ₹145, with a market capitalization of ₹2,006 Cr. Revenue trends indicate a steady increase, with sales rising from ₹1,564 Cr in FY 2022 to ₹1,687 Cr in FY 2023, and projected to reach ₹2,123 Cr in FY 2025. This growth trajectory is evident in the quarterly sales figures, which recorded ₹414.18 Cr in September 2022 and rose to ₹455.44 Cr by September 2023. The company’s operating profit margins (OPM) have varied, peaking at 17.44% in March 2024, although they faced a decline to 9.46% in September 2025. Such fluctuations highlight the company’s capacity to adapt to market dynamics, though external factors may pose challenges to maintaining consistent growth.
Profitability and Efficiency Metrics
Profitability metrics reveal a mixed performance for SHK. The return on equity (ROE) stood at 7.70%, with return on capital employed (ROCE) at 10.3%. The operating profit (₹217 Cr in FY 2023) and net profit (₹63 Cr in FY 2023) reflect the company’s operational efficiency amidst competitive pressures. However, net profit margins have shown volatility, declining from 9.55% in FY 2022 to 3.74% in FY 2023 before recovering to 3.50% in FY 2025. The interest coverage ratio (ICR) of 6.49x illustrates a robust capacity to meet interest obligations, although the cash conversion cycle (CCC) of 187 days indicates potential inefficiencies in working capital management. These figures suggest SHK has the potential for profitability but may need to enhance operational efficiencies to improve margins further.
Balance Sheet Strength and Financial Ratios
SHK’s balance sheet reflects a solid financial standing, with total assets amounting to ₹2,660 Cr as of March 2025, against total liabilities of ₹2,660 Cr, indicating a balanced approach to asset management. The company’s reserves have increased to ₹1,191 Cr, while borrowings stood at ₹889 Cr, resulting in a manageable debt-to-equity ratio of 0.58. The price-to-book value (P/BV) ratio was recorded at 1.93x, suggesting the stock is trading at a reasonable premium over its book value. Additionally, the current ratio of 1.39 indicates adequate short-term liquidity. The company’s ability to maintain a healthy level of reserves while managing its debt levels positions it well for future growth opportunities and financial stability.
Shareholding Pattern and Investor Confidence
The shareholding structure of SHK shows a diverse ownership landscape, with promoters holding 54.87% of the shares, indicating strong insider confidence. Foreign institutional investors (FIIs) have a stake of 7.36%, while domestic institutional investors (DIIs) own 5.69%. The public holds 32.08% of the shares, reflecting a healthy distribution among retail investors. Over the past year, there has been a slight decline in promoter holding from 58.95% in June 2023 to the current level, which may raise questions about insider confidence. However, the increase in public shareholding from 26.19% in December 2022 to 32.08% in September 2025 suggests growing interest among retail investors. This diverse ownership can enhance market stability and investor confidence, although the declining promoter stake may warrant further observation.
Outlook, Risks, and Final Insight
Looking ahead, SHK faces both opportunities and challenges. The company’s continued revenue growth, alongside a solid balance sheet, positions it favorably within the specialty chemicals sector. However, risks such as fluctuating profit margins, operational inefficiencies, and a declining promoter stake could impact investor sentiment. The company must focus on improving operational efficiencies and managing costs to enhance profitability. Additionally, external factors such as raw material price volatility and regulatory changes in the chemicals sector could pose risks to future growth. To navigate these challenges, SHK may need to adopt strategic initiatives aimed at bolstering operational performance and maintaining investor confidence. Engaging in innovation and expanding product lines could also serve to mitigate risks and capitalize on market opportunities.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Diamines & Chemicals Ltd | 238 Cr. | 243 | 498/228 | 158 | 0.41 % | 3.33 % | 1.78 % | 10.0 | |
| Deco-Mica Ltd | 25.2 Cr. | 60.0 | 90.0/56.0 | 13.8 | 64.2 | 0.00 % | 11.8 % | 7.51 % | 10.0 |
| Andhra Sugars Ltd | 909 Cr. | 67.0 | 91.6/64.9 | 11.4 | 121 | 1.19 % | 3.54 % | 2.51 % | 2.00 |
| Tamil Nadu Petro Products Ltd | 833 Cr. | 92.6 | 130/63.6 | 8.33 | 109 | 1.30 % | 6.97 % | 5.10 % | 10.0 |
| SRF Ltd | 79,350 Cr. | 2,677 | 3,325/2,505 | 42.9 | 447 | 0.34 % | 12.3 % | 10.4 % | 10.0 |
| Industry Average | 13,159.67 Cr | 1,107.28 | 29.35 | 204.33 | 0.47% | 10.57% | 8.89% | 7.60 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 414.18 | 384.90 | 472.43 | 422.56 | 455.44 | 471.68 | 513.34 | 470.31 | 542.50 | 543.21 | 567.38 | 580.63 | 553.89 |
| Expenses | 362.52 | 341.46 | 405.18 | 354.61 | 383.81 | 395.82 | 423.80 | 392.05 | 462.38 | 479.56 | 493.95 | 507.62 | 501.50 |
| Operating Profit | 51.66 | 43.44 | 67.25 | 67.95 | 71.63 | 75.86 | 89.54 | 78.26 | 80.12 | 63.65 | 73.43 | 73.01 | 52.39 |
| OPM % | 12.47% | 11.29% | 14.23% | 16.08% | 15.73% | 16.08% | 17.44% | 16.64% | 14.77% | 11.72% | 12.94% | 12.57% | 9.46% |
| Other Income | 8.99 | 1.53 | -20.44 | 1.62 | 1.80 | 1.90 | -0.18 | -120.29 | 20.65 | 0.89 | 61.15 | 3.04 | 1.06 |
| Interest | 5.08 | 6.35 | 7.47 | 9.82 | 9.95 | 10.35 | 10.04 | 9.89 | 12.82 | 13.82 | 12.89 | 13.07 | 13.91 |
| Depreciation | 20.42 | 19.72 | 20.52 | 20.85 | 22.31 | 21.68 | 22.03 | 22.49 | 24.18 | 23.35 | 24.68 | 26.37 | 27.38 |
| Profit before tax | 35.15 | 18.90 | 18.82 | 38.90 | 41.17 | 45.73 | 57.29 | -74.41 | 63.77 | 27.37 | 97.01 | 36.61 | 12.16 |
| Tax % | 28.22% | 29.31% | 94.00% | 28.46% | 26.74% | 29.74% | 41.65% | 16.68% | 37.57% | 36.02% | -5.67% | 30.21% | 24.59% |
| Net Profit | 25.23 | 13.36 | 1.13 | 27.83 | 30.16 | 32.13 | 33.43 | -86.82 | 39.81 | 17.51 | 102.51 | 25.55 | 9.17 |
| EPS in Rs | 1.75 | 0.94 | 0.17 | 1.96 | 2.12 | 2.33 | 2.45 | -6.25 | 2.87 | 1.27 | 7.41 | 1.85 | 0.66 |
Last Updated: December 29, 2025, 7:36 am
Below is a detailed analysis of the quarterly data for S H Kelkar & Company Ltd (SHK) based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 553.89 Cr.. The value appears to be declining and may need further review. It has decreased from 580.63 Cr. (Jun 2025) to 553.89 Cr., marking a decrease of 26.74 Cr..
- For Expenses, as of Sep 2025, the value is 501.50 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 507.62 Cr. (Jun 2025) to 501.50 Cr., marking a decrease of 6.12 Cr..
- For Operating Profit, as of Sep 2025, the value is 52.39 Cr.. The value appears to be declining and may need further review. It has decreased from 73.01 Cr. (Jun 2025) to 52.39 Cr., marking a decrease of 20.62 Cr..
- For OPM %, as of Sep 2025, the value is 9.46%. The value appears to be declining and may need further review. It has decreased from 12.57% (Jun 2025) to 9.46%, marking a decrease of 3.11%.
- For Other Income, as of Sep 2025, the value is 1.06 Cr.. The value appears to be declining and may need further review. It has decreased from 3.04 Cr. (Jun 2025) to 1.06 Cr., marking a decrease of 1.98 Cr..
- For Interest, as of Sep 2025, the value is 13.91 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.07 Cr. (Jun 2025) to 13.91 Cr., marking an increase of 0.84 Cr..
- For Depreciation, as of Sep 2025, the value is 27.38 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.37 Cr. (Jun 2025) to 27.38 Cr., marking an increase of 1.01 Cr..
- For Profit before tax, as of Sep 2025, the value is 12.16 Cr.. The value appears to be declining and may need further review. It has decreased from 36.61 Cr. (Jun 2025) to 12.16 Cr., marking a decrease of 24.45 Cr..
- For Tax %, as of Sep 2025, the value is 24.59%. The value appears to be improving (decreasing) as expected. It has decreased from 30.21% (Jun 2025) to 24.59%, marking a decrease of 5.62%.
- For Net Profit, as of Sep 2025, the value is 9.17 Cr.. The value appears to be declining and may need further review. It has decreased from 25.55 Cr. (Jun 2025) to 9.17 Cr., marking a decrease of 16.38 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.66. The value appears to be declining and may need further review. It has decreased from 1.85 (Jun 2025) to 0.66, marking a decrease of 1.19.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:43 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 761 | 834 | 925 | 981 | 1,021 | 1,048 | 1,114 | 1,322 | 1,564 | 1,687 | 1,841 | 2,123 | 2,245 |
| Expenses | 628 | 716 | 774 | 814 | 862 | 908 | 955 | 1,083 | 1,350 | 1,469 | 1,537 | 1,828 | 1,983 |
| Operating Profit | 132 | 119 | 151 | 167 | 159 | 141 | 160 | 239 | 215 | 217 | 304 | 296 | 262 |
| OPM % | 17% | 14% | 16% | 17% | 16% | 13% | 14% | 18% | 14% | 13% | 17% | 14% | 12% |
| Other Income | 12 | 25 | 10 | 12 | 13 | 21 | -28 | 36 | 6 | -8 | 5 | -38 | 66 |
| Interest | 18 | 19 | 22 | 6 | 5 | 16 | 26 | 20 | 16 | 24 | 40 | 49 | 54 |
| Depreciation | 19 | 29 | 30 | 19 | 24 | 31 | 52 | 62 | 72 | 80 | 86 | 95 | 102 |
| Profit before tax | 109 | 94 | 110 | 153 | 143 | 115 | 54 | 194 | 132 | 104 | 183 | 114 | 173 |
| Tax % | 27% | 26% | 34% | 31% | 35% | 24% | 34% | 26% | -13% | 40% | 32% | 36% | |
| Net Profit | 79 | 70 | 73 | 105 | 94 | 88 | 36 | 144 | 149 | 63 | 124 | 73 | 155 |
| EPS in Rs | 5,980.35 | 5.32 | 5.05 | 7.25 | 6.49 | 6.12 | 2.53 | 10.24 | 10.73 | 4.42 | 8.84 | 5.29 | 11.19 |
| Dividend Payout % | 19% | 28% | 30% | 24% | 27% | 0% | 38% | 17% | 7% | 45% | 8% | 19% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -11.39% | 4.29% | 43.84% | -10.48% | -6.38% | -59.09% | 300.00% | 3.47% | -57.72% | 96.83% | -41.13% |
| Change in YoY Net Profit Growth (%) | 0.00% | 15.68% | 39.55% | -54.31% | 4.09% | -52.71% | 359.09% | -296.53% | -61.19% | 154.54% | -137.95% |
S H Kelkar & Company Ltd (SHK) has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 11% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 11% |
| 3 Years: | -15% |
| TTM: | 15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 27% |
| 3 Years: | 21% |
| 1 Year: | 9% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 11% |
| 3 Years: | 8% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 1:15 pm
Balance Sheet
Last Updated: December 4, 2025, 1:54 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 132 | 145 | 145 | 145 | 145 | 141 | 141 | 138 | 138 | 138 | 138 | 138 |
| Reserves | 467 | 368 | 571 | 667 | 712 | 719 | 683 | 810 | 875 | 926 | 1,074 | 1,134 | 1,191 |
| Borrowings | 212 | 252 | 85 | 74 | 172 | 342 | 365 | 518 | 698 | 620 | 666 | 832 | 889 |
| Other Liabilities | 169 | 187 | 201 | 187 | 246 | 222 | 277 | 405 | 568 | 518 | 502 | 556 | 587 |
| Total Liabilities | 861 | 939 | 1,003 | 1,073 | 1,275 | 1,427 | 1,466 | 1,874 | 2,279 | 2,202 | 2,381 | 2,660 | 2,805 |
| Fixed Assets | 251 | 274 | 227 | 296 | 352 | 462 | 472 | 741 | 959 | 914 | 933 | 953 | 1,052 |
| CWIP | 50 | 10 | 18 | 7 | 60 | 38 | 18 | 28 | 9 | 26 | 13 | 46 | 59 |
| Investments | 0 | 0 | 35 | 50 | 96 | 97 | 97 | 1 | 1 | 23 | 10 | 11 | 13 |
| Other Assets | 559 | 655 | 722 | 720 | 767 | 830 | 879 | 1,103 | 1,309 | 1,239 | 1,425 | 1,650 | 1,681 |
| Total Assets | 861 | 939 | 1,003 | 1,073 | 1,275 | 1,427 | 1,466 | 1,874 | 2,279 | 2,202 | 2,381 | 2,660 | 2,805 |
Below is a detailed analysis of the balance sheet data for S H Kelkar & Company Ltd (SHK) based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 138.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 138.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,191.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,134.00 Cr. (Mar 2025) to 1,191.00 Cr., marking an increase of 57.00 Cr..
- For Borrowings, as of Sep 2025, the value is 889.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 832.00 Cr. (Mar 2025) to 889.00 Cr., marking an increase of 57.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 587.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 556.00 Cr. (Mar 2025) to 587.00 Cr., marking an increase of 31.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,805.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,660.00 Cr. (Mar 2025) to 2,805.00 Cr., marking an increase of 145.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,052.00 Cr.. The value appears strong and on an upward trend. It has increased from 953.00 Cr. (Mar 2025) to 1,052.00 Cr., marking an increase of 99.00 Cr..
- For CWIP, as of Sep 2025, the value is 59.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Mar 2025) to 59.00 Cr., marking an increase of 13.00 Cr..
- For Investments, as of Sep 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 2.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,681.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,650.00 Cr. (Mar 2025) to 1,681.00 Cr., marking an increase of 31.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,805.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,660.00 Cr. (Mar 2025) to 2,805.00 Cr., marking an increase of 145.00 Cr..
Notably, the Reserves (1,191.00 Cr.) exceed the Borrowings (889.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -80.00 | -133.00 | 66.00 | 93.00 | -13.00 | -201.00 | -205.00 | -279.00 | -483.00 | -403.00 | -362.00 | -536.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 86 | 85 | 90 | 81 | 99 | 99 | 104 | 103 | 108 | 95 | 97 | 87 |
| Inventory Days | 255 | 252 | 239 | 247 | 233 | 239 | 201 | 216 | 225 | 228 | 243 | 227 |
| Days Payable | 80 | 76 | 116 | 78 | 104 | 86 | 103 | 125 | 143 | 138 | 132 | 126 |
| Cash Conversion Cycle | 261 | 261 | 213 | 250 | 228 | 252 | 202 | 195 | 190 | 185 | 209 | 187 |
| Working Capital Days | 157 | 70 | 135 | 128 | 110 | 86 | 55 | 91 | 90 | 88 | 63 | 62 |
| ROCE % | 18% | 14% | 17% | 19% | 17% | 12% | 10% | 15% | 10% | 8% | 12% | 10% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Bandhan Small Cap Fund | 5,180,624 | 0.49 | 88.62 | 3,942,304 | 2025-12-15 00:19:01 | 31.41% |
| LIC MF Small Cap Fund | 319,836 | 0.88 | 5.47 | N/A | N/A | N/A |
| LIC MF Balanced Advantage Fund | 303,558 | 0.69 | 5.19 | N/A | N/A | N/A |
| LIC MF Focused Fund | 301,129 | 2.98 | 5.15 | N/A | N/A | N/A |
| LIC MF Dividend Yield Fund | 294,810 | 0.72 | 5.04 | N/A | N/A | N/A |
| Tata Childrens Fund | 150,000 | 0.7 | 2.57 | N/A | N/A | N/A |
| LIC MF Value Fund | 119,795 | 1 | 2.05 | 125,240 | 2025-12-15 00:19:01 | -4.35% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 5.31 | 8.93 | 4.53 | 10.81 | 10.48 |
| Diluted EPS (Rs.) | 5.31 | 8.93 | 4.53 | 10.81 | 10.48 |
| Cash EPS (Rs.) | 12.22 | 15.38 | 10.37 | 15.98 | 14.52 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.89 | 87.62 | 79.66 | 79.01 | 67.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.89 | 87.62 | 79.66 | 79.01 | 67.55 |
| Revenue From Operations / Share (Rs.) | 153.40 | 139.43 | 121.84 | 113.00 | 93.54 |
| PBDIT / Share (Rs.) | 23.18 | 22.60 | 16.55 | 16.77 | 18.35 |
| PBIT / Share (Rs.) | 16.34 | 16.15 | 10.74 | 11.59 | 14.00 |
| PBT / Share (Rs.) | 8.39 | 13.17 | 7.55 | 9.55 | 13.68 |
| Net Profit / Share (Rs.) | 5.37 | 8.93 | 4.56 | 10.79 | 10.17 |
| NP After MI And SOA / Share (Rs.) | 5.29 | 8.84 | 4.42 | 10.73 | 10.24 |
| PBDIT Margin (%) | 15.11 | 16.21 | 13.58 | 14.84 | 19.61 |
| PBIT Margin (%) | 10.65 | 11.58 | 8.81 | 10.25 | 14.96 |
| PBT Margin (%) | 5.47 | 9.44 | 6.19 | 8.45 | 14.62 |
| Net Profit Margin (%) | 3.50 | 6.40 | 3.74 | 9.55 | 10.87 |
| NP After MI And SOA Margin (%) | 3.44 | 6.34 | 3.62 | 9.49 | 10.94 |
| Return on Networth / Equity (%) | 5.75 | 10.09 | 5.74 | 14.66 | 15.20 |
| Return on Capital Employeed (%) | 14.55 | 15.22 | 9.82 | 10.20 | 14.93 |
| Return On Assets (%) | 2.72 | 5.09 | 2.75 | 6.46 | 7.62 |
| Long Term Debt / Equity (X) | 0.13 | 0.14 | 0.29 | 0.35 | 0.34 |
| Total Debt / Equity (X) | 0.58 | 0.50 | 0.53 | 0.62 | 0.51 |
| Asset Turnover Ratio (%) | 0.83 | 0.83 | 0.74 | 0.55 | 0.60 |
| Current Ratio (X) | 1.39 | 1.46 | 1.70 | 1.70 | 1.82 |
| Quick Ratio (X) | 0.75 | 0.75 | 0.85 | 0.93 | 1.07 |
| Inventory Turnover Ratio (X) | 3.09 | 3.06 | 1.72 | 1.58 | 1.82 |
| Dividend Payout Ratio (NP) (%) | 14.17 | 22.61 | 16.96 | 7.13 | 9.76 |
| Dividend Payout Ratio (CP) (%) | 6.18 | 13.07 | 7.32 | 4.81 | 6.85 |
| Earning Retention Ratio (%) | 85.83 | 77.39 | 83.04 | 92.87 | 90.24 |
| Cash Earning Retention Ratio (%) | 93.82 | 86.93 | 92.68 | 95.19 | 93.15 |
| Interest Coverage Ratio (X) | 6.49 | 7.58 | 9.59 | 14.35 | 15.19 |
| Interest Coverage Ratio (Post Tax) (X) | 3.75 | 3.99 | 4.49 | 10.97 | 8.69 |
| Enterprise Value (Cr.) | 3118.96 | 3356.30 | 1912.25 | 2576.78 | 1935.94 |
| EV / Net Operating Revenue (X) | 1.47 | 1.74 | 1.13 | 1.65 | 1.46 |
| EV / EBITDA (X) | 9.72 | 10.73 | 8.35 | 11.10 | 7.46 |
| MarketCap / Net Operating Revenue (X) | 1.16 | 1.47 | 0.81 | 1.27 | 1.19 |
| Retention Ratios (%) | 85.82 | 77.38 | 83.03 | 92.86 | 90.23 |
| Price / BV (X) | 1.93 | 2.34 | 1.29 | 1.96 | 1.66 |
| Price / Net Operating Revenue (X) | 1.16 | 1.47 | 0.81 | 1.27 | 1.19 |
| EarningsYield | 0.02 | 0.04 | 0.04 | 0.07 | 0.09 |
After reviewing the key financial ratios for S H Kelkar & Company Ltd (SHK), here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.31. This value is within the healthy range. It has decreased from 8.93 (Mar 24) to 5.31, marking a decrease of 3.62.
- For Diluted EPS (Rs.), as of Mar 25, the value is 5.31. This value is within the healthy range. It has decreased from 8.93 (Mar 24) to 5.31, marking a decrease of 3.62.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.22. This value is within the healthy range. It has decreased from 15.38 (Mar 24) to 12.22, marking a decrease of 3.16.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.89. It has increased from 87.62 (Mar 24) to 91.89, marking an increase of 4.27.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.89. It has increased from 87.62 (Mar 24) to 91.89, marking an increase of 4.27.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 153.40. It has increased from 139.43 (Mar 24) to 153.40, marking an increase of 13.97.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 23.18. This value is within the healthy range. It has increased from 22.60 (Mar 24) to 23.18, marking an increase of 0.58.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.34. This value is within the healthy range. It has increased from 16.15 (Mar 24) to 16.34, marking an increase of 0.19.
- For PBT / Share (Rs.), as of Mar 25, the value is 8.39. This value is within the healthy range. It has decreased from 13.17 (Mar 24) to 8.39, marking a decrease of 4.78.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. It has decreased from 8.93 (Mar 24) to 5.37, marking a decrease of 3.56.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 5.29. This value is within the healthy range. It has decreased from 8.84 (Mar 24) to 5.29, marking a decrease of 3.55.
- For PBDIT Margin (%), as of Mar 25, the value is 15.11. This value is within the healthy range. It has decreased from 16.21 (Mar 24) to 15.11, marking a decrease of 1.10.
- For PBIT Margin (%), as of Mar 25, the value is 10.65. This value is within the healthy range. It has decreased from 11.58 (Mar 24) to 10.65, marking a decrease of 0.93.
- For PBT Margin (%), as of Mar 25, the value is 5.47. This value is below the healthy minimum of 10. It has decreased from 9.44 (Mar 24) to 5.47, marking a decrease of 3.97.
- For Net Profit Margin (%), as of Mar 25, the value is 3.50. This value is below the healthy minimum of 5. It has decreased from 6.40 (Mar 24) to 3.50, marking a decrease of 2.90.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.44. This value is below the healthy minimum of 8. It has decreased from 6.34 (Mar 24) to 3.44, marking a decrease of 2.90.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.75. This value is below the healthy minimum of 15. It has decreased from 10.09 (Mar 24) to 5.75, marking a decrease of 4.34.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.55. This value is within the healthy range. It has decreased from 15.22 (Mar 24) to 14.55, marking a decrease of 0.67.
- For Return On Assets (%), as of Mar 25, the value is 2.72. This value is below the healthy minimum of 5. It has decreased from 5.09 (Mar 24) to 2.72, marking a decrease of 2.37.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.13. This value is below the healthy minimum of 0.2. It has decreased from 0.14 (Mar 24) to 0.13, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.58. This value is within the healthy range. It has increased from 0.50 (Mar 24) to 0.58, marking an increase of 0.08.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.83. There is no change compared to the previous period (Mar 24) which recorded 0.83.
- For Current Ratio (X), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 1.5. It has decreased from 1.46 (Mar 24) to 1.39, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.75.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.09. This value is below the healthy minimum of 4. It has increased from 3.06 (Mar 24) to 3.09, marking an increase of 0.03.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14.17. This value is below the healthy minimum of 20. It has decreased from 22.61 (Mar 24) to 14.17, marking a decrease of 8.44.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.18. This value is below the healthy minimum of 20. It has decreased from 13.07 (Mar 24) to 6.18, marking a decrease of 6.89.
- For Earning Retention Ratio (%), as of Mar 25, the value is 85.83. This value exceeds the healthy maximum of 70. It has increased from 77.39 (Mar 24) to 85.83, marking an increase of 8.44.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.82. This value exceeds the healthy maximum of 70. It has increased from 86.93 (Mar 24) to 93.82, marking an increase of 6.89.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.49. This value is within the healthy range. It has decreased from 7.58 (Mar 24) to 6.49, marking a decrease of 1.09.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.75. This value is within the healthy range. It has decreased from 3.99 (Mar 24) to 3.75, marking a decrease of 0.24.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,118.96. It has decreased from 3,356.30 (Mar 24) to 3,118.96, marking a decrease of 237.34.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.47. This value is within the healthy range. It has decreased from 1.74 (Mar 24) to 1.47, marking a decrease of 0.27.
- For EV / EBITDA (X), as of Mar 25, the value is 9.72. This value is within the healthy range. It has decreased from 10.73 (Mar 24) to 9.72, marking a decrease of 1.01.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.47 (Mar 24) to 1.16, marking a decrease of 0.31.
- For Retention Ratios (%), as of Mar 25, the value is 85.82. This value exceeds the healthy maximum of 70. It has increased from 77.38 (Mar 24) to 85.82, marking an increase of 8.44.
- For Price / BV (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has decreased from 2.34 (Mar 24) to 1.93, marking a decrease of 0.41.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.47 (Mar 24) to 1.16, marking a decrease of 0.31.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.02, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in S H Kelkar & Company Ltd (SHK):
- Net Profit Margin: 3.5%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14.55% (Industry Average ROCE: 10.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.75% (Industry Average ROE: 8.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.75
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 20.2 (Industry average Stock P/E: 29.35)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.58
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.5%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | Devkaran Mansion, Mumbai Maharashtra 400002 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ramesh Vaze | Chairman & Non-Exe.Director |
| Mr. Kedar Vaze | WholeTime Director & Group CEO |
| Mrs. Prabha Vaze | Non Executive Director |
| Mr. Deepak Raj Bindra | Independent Director |
| Mr. Shrikant Oka | Independent Director |
| Mr. Vasant Gujarathi | Independent Director |
| Ms. Neela Bhattacherjee | Independent Director |
FAQ
What is the intrinsic value of S H Kelkar & Company Ltd (SHK)?
S H Kelkar & Company Ltd (SHK)'s intrinsic value (as of 22 January 2026) is ₹121.42 which is 16.26% lower the current market price of ₹145.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,013 Cr. market cap, FY2025-2026 high/low of ₹276/142, reserves of ₹1,191 Cr, and liabilities of ₹2,805 Cr.
What is the Market Cap of S H Kelkar & Company Ltd (SHK)?
The Market Cap of S H Kelkar & Company Ltd (SHK) is 2,013 Cr..
What is the current Stock Price of S H Kelkar & Company Ltd (SHK) as on 22 January 2026?
The current stock price of S H Kelkar & Company Ltd (SHK) as on 22 January 2026 is ₹145.
What is the High / Low of S H Kelkar & Company Ltd (SHK) stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of S H Kelkar & Company Ltd (SHK) stocks is ₹276/142.
What is the Stock P/E of S H Kelkar & Company Ltd (SHK)?
The Stock P/E of S H Kelkar & Company Ltd (SHK) is 20.2.
What is the Book Value of S H Kelkar & Company Ltd (SHK)?
The Book Value of S H Kelkar & Company Ltd (SHK) is 96.1.
What is the Dividend Yield of S H Kelkar & Company Ltd (SHK)?
The Dividend Yield of S H Kelkar & Company Ltd (SHK) is 0.69 %.
What is the ROCE of S H Kelkar & Company Ltd (SHK)?
The ROCE of S H Kelkar & Company Ltd (SHK) is 10.3 %.
What is the ROE of S H Kelkar & Company Ltd (SHK)?
The ROE of S H Kelkar & Company Ltd (SHK) is 7.70 %.
What is the Face Value of S H Kelkar & Company Ltd (SHK)?
The Face Value of S H Kelkar & Company Ltd (SHK) is 10.0.